Scanlan Sean F. - Insider Non-Derivative Transactions at TREACE MEDICAL CONCEPTS, INC. (TMCI) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Sep 12, 2024, Scanlan Sean F.'s relationship to TREACE MEDICAL CONCEPTS, INC. (TMCI) is Officer (Chief Innovation Officer), and currently has 250,074 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other TMCI insiders.

Data Source: SEC.
Scanlan Sean F. - Insider Non-Derivative Transactions of TMCI Common Stock
Scanlan Sean F. - Insider Non-Derivative Transactions at TMCI
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Sep 13, 2024 M -- (Common Stock) 33750 0.1 250074
Aug 10, 2024 Acquisition -- (Common Stock) 120900 0 216324
Mar 11, 2024 F -- (Common Stock) 1396 0 95424
Mar 9, 2024 F -- (Common Stock) 389 0 96820
Jan 11, 2024 Acquisition -- (Common Stock) 65025 0 97209
Nov 3, 2023 F -- (Common Stock) 211 0 32184
May 17, 2023 Sell -- (Common Stock) 25000 25.44 32395
May 17, 2023 M -- (Common Stock) 25000 0.1 57395
Mar 11, 2023 Acquisition -- (Common Stock) 22925 0 32395
Mar 10, 2023 Sell -- (Common Stock) 505 24.41 9470
Feb 16, 2023 Sell -- (Common Stock) 25000 21.69 9975
Feb 16, 2023 M -- (Common Stock) 25000 0.1 34975
Jan 13, 2023 Sell -- (Common Stock) 25000 25.57 9975
Jan 13, 2023 M -- (Common Stock) 25000 0.1 34975